Our current study was to evaluate the role of PI3K signaling in NIS expression, trafficking and iodide uptake ability in MCF-7 cells and in human breast tumors, as activating mutations of the PI3K p110α subunit are frequent in human breast cancers [11] and cell lines [12]. Here, SLC5A5 is linked to breast carcinoma.